Dr.Guohong Han: Combining Targeted Therapy to Reduce Postoperative Liver Cancer Recurrence and Prolong Survival in Cirrhotic Patients with Anticoagulation
The 58th Annual Meeting of the European Association for the Study of the Liver (EASL 2023) and the 2023 EASL Congress concluded successfully on June 24th in Vienna, Austria, three…